Screening for Proteinuria and Chronic Kidney Disease Risk Factors in Kinshasa: A World Kidney Day 2007 Study

被引:22
作者
Sumaili, Ernest K. [1 ,4 ]
Nseka, Nazaire M. [1 ]
Lepira, Francois B. [1 ]
Krzesinski, Jean Marie [4 ]
Makulo, Jean Robert R. [1 ]
Bukabau, Justine B. [1 ]
Nkoy, Josee B. [2 ]
Mokoli, Vieux M. [1 ]
Longokolo, Murielle M. [1 ]
Owandjalola, Julie A. [1 ]
Kayembe, Patrick K. [3 ]
机构
[1] Univ Kinshasa, Nephrol Unit, Kinshasa, DEM REP CONGO
[2] St Joseph Hosp Kinshasa, Kinshasa, DEM REP CONGO
[3] Univ Kinshasa, Sch Publ Hlth, Med Epidemiol & Biostat Unit, Kinshasa, DEM REP CONGO
[4] Univ Liege, Div Nephrology Transplantat, BE-4000 Liege, Belgium
来源
NEPHRON CLINICAL PRACTICE | 2008年 / 110卷 / 04期
关键词
Chronic kidney disease; Diabetes mellitus; Developing countries; Early detection;
D O I
10.1159/000167869
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Although screening programs for chronic kidney disease (CKD) may be of great value, these programs are not yet implemented in the Democratic Republic of Congo. This study focused on proteinuria and examined its prevalence in terms of the number needed to screen for the different risk factors of CKD. Such knowledge would guide the utility of population screening to prevent end-stage renal disease. Methods: A cross-sectional survey was conducted in Kinshasa on the Second World Kidney Day. A sample of 3,018 subjects was interviewed and the following measurements were performed: blood pressure, body mass index, glycemia and urine protein. Logistic regression analysis was used to identify determinants of proteinuria. Results: The prevalence of proteinuria was 17.1% (95% CI 15.8-18.6). Other CKD risk factors identified were: hypertension, diabetes mellitus, obesity and metabolic syndrome. To identify 1 case of proteinuria, one would need to screen 4 persons with diabetes, 5 persons with hypertension, 4 subjects having metabolic syndrome, 5 persons aged 6 72 years and 9 persons without any of the conditions mentioned above. Age, overweight and diabetes were the strongest factors associated with proteinuria. Conclusions: This study indicates that proteinuria and traditional risk factors for CKD are very prevalent in Kinshasa. Realistic policies to stem these conditions should be a public health priority. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:C220 / C228
页数:9
相关论文
共 43 条
[1]   CKD prevention in Sub-Saharan Africa: A call for governmental, nongovernmental, and community support [J].
Arogundade, Fatiu A. ;
Barsoum, Rashad S. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (03) :515-523
[2]  
BARSOUM RS, 2005, KIDNEY DIS DEV WORLD, P1
[3]   Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications [J].
Bianchi, S ;
Bigazzi, R ;
Campese, VM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (06) :973-995
[4]   Screening for proteinuria in US adults - A cost-effectiveness analysis [J].
Boulware, LE ;
Jaar, BG ;
Tarver-Carr, ME ;
Brancati, FL ;
Powe, NR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (23) :3101-3114
[5]   Urinary albumin excretion as a predictor of the development of hypertension in the general population [J].
Brantsma, Auke H. ;
Bakker, Stephan J. L. ;
de Zeeuw, Dick ;
de Jong, Paul E. ;
Gansevoort, Ronald T. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (02) :331-335
[6]   Early detection of kidney disease in community settings: The Kidney Early Evaluation Program (KEEP) [J].
Brown, WW ;
Peters, RM ;
Ohmit, SE ;
Keane, WF ;
Collins, A ;
Chen, SC ;
King, K ;
Klag, MJ ;
Molony, DA ;
Flack, JM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (01) :22-35
[7]   The metabolic syndrome and chronic kidney disease in US adults [J].
Chen, J ;
Muntner, P ;
Hamm, LL ;
Jones, DW ;
Batuman, V ;
Fonseca, V ;
Whelton, PK ;
He, J .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (03) :167-174
[8]   School urinalysis screening in Korea [J].
Cho, Byoung-Soo ;
Kim, Sung-Do .
NEPHROLOGY, 2007, 12 :S3-S7
[9]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497